BetterLife Pharma Inc. (CSE:BETR)

Canada flag Canada · Delayed Price · Currency is CAD
0.0650
0.00 (0.00%)
May 11, 2026, 1:55 PM EST
Market Cap10.05M -25.1%
Revenue (ttm)n/a
Net Income-1.85M
EPS-0.02
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume93,846
Average Volume146,954
Open0.0650
Previous Close0.0650
Day's Range0.0650 - 0.0650
52-Week Range0.0400 - 0.1200
Beta0.54
RSI51.59
Earnings DateMay 29, 2026

About BetterLife Pharma

BetterLife Pharma Inc., a biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight viral infections. The company’s products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety disorder, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to t... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 7
Stock Exchange Canadian Securities Exchange
Ticker Symbol BETR

Financial Performance

Financial Statements